Presidential oration: the 18 annual conference of the Indian academy of neurology, trichi, Tamil Nadu, september 24-26, 2010, epilepsy care in developing countries.
Nearly 80% of the 50 million people with epilepsy worldwide reside in developing countries that are least equipped to tackle the enormous medical, social and economic challenges posed by epilepsy. These include widespread poverty, illiteracy, inefficient and unevenly distributed health care systems, and social stigma and misconceptions associated with epilepsy. Several studies have reported that a large proportion of patients with epilepsy in developing countries never receive appropriate treatment for their condition, and many, though diagnosed and initiated on treatment, soon discontinue treatment. Unaffordable cost of treatment, unavailability of antiepileptic drugs, and superstitious and cultural beliefs contribute to high epilepsy treatment gap in resource-poor countries. A significant proportion of the current burden of epilepsy in developing countries can be minimized by educating the public about the positive aspects of life with epilepsy and the primary and secondary physicians about current trends in the management of epilepsies, scaling up routine availability of low-cost antiepileptic drugs, and developing cost-effective epilepsy surgery programs.
R. Madhavan Nayar Center for Comprehensive Epilepsy Care, Sree Chitra Tirunal Institute for Medical sciences and Technology, Trivandrum, Kerala, India.
Kurupath
K
Radhakrishnan
Neurol India. 2008 Apr-Jun;56(2):127-32
18688135
Seizure. 2006 Sep;15(6):409-15
16781171
Epilepsia. 2002;43 Suppl 6:34-6
12190977
Epilepsia. 2008 Sep;49(9):1491-503
18557778
Epilepsy Behav. 2006 Nov;9(3):492-7
16971188
Nat Rev Neurol. 2009 Jun;5(6):323-30
19455183
Brain Dev. 2007 Oct;29(9):577-85
17507193
Epilepsia. 1999 Feb;40(2):179-85
9952264
Epilepsia. 2002;43 Suppl 6:7-8
12190967
Epilepsia. 2002 Dec;43(12):1583-9
12460262
Seizure. 2007 Oct;16(7):601-7
17576079
Epilepsia. 2002 Mar;43(3):311-6
11906517
N Engl J Med. 2000 Feb 3;342(5):314-9
10660394
Epilepsia. 2006 Oct;47(10):1700-22
17054693
Epilepsia. 2005 May;46(5):751-9
15857443
Lancet Neurol. 2006 Jan;5(1):46-52
16361022
Neurology. 2003 May 13;60(9):1544-5
12743252
Lancet Neurol. 2007 Jun;6(6):533-43
17509488
Neurol India. 1998 Jan-Mar;46(1):1-4
29504587
Epilepsia. 2003;44 Suppl 1:48-50
12558833
Epilepsia. 2000 Aug;41(8):1027-35
10961631
Epilepsia. 2008 Mar;49(3):381-5
17941843
Epilepsy Res. 2005 Aug-Sep;66(1-3):63-74
16125900
Lancet. 2001 Apr 28;357(9265):1316-20
11343735
Lancet Neurol. 2005 Jan;4(1):21-31
15620854
Epilepsia. 2007 May;48(5):1007-10
17386055
Epilepsia. 2004 Nov;45(11):1405-15
15509242
Soc Sci Med. 1995 May;40(10):1319-30
7638642
Neurol India. 2009 Jan-Feb;57(1):4-6
19305068
Epilepsia. 2001 Jan;42(1):136-49
11207798
Eur J Neurol. 2005 Apr;12(4):245-53
15804240
Epilepsia. 2006 Jul;47(7):1225-31
16886987
Epilepsia. 1980 Oct;21(5):509-18
7418667